Tetratherix (ASX:TTX) FCF Margin %: 0.00% (As of Dec. 2025)


ASX:TTX Tetratherix Ltd ASX:TTX
15 GF Score
Price A$6.12
View Full Analysis

What is Tetratherix FCF Margin %?

Tetratherix ASX:TTX -1.45% 15 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:TTX with a GF Score™ of 15/100. Among 959 Biotechnology companies, Tetratherix ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tetratherix's Free Cash Flow for the six months ended in Dec. 2025 was A$-6.59 Mil. Tetratherix's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Tetratherix's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Tetratherix's current FCF Yield % is -2.47%.

The historical rank and industry rank for Tetratherix's FCF Margin % or its related term are showing as below:


ASX:TTX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Tetratherix FCF Margin % Related Terms

Tetratherix FCF Margin % Historical Data

* Premium members only.

The historical data trend for Tetratherix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix FCF Margin % Chart

Tetratherix Annual Data
Trend Jun23 Jun24 Jun25
FCF Margin %
0.00 0.00 0.00

Tetratherix Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ASX:TTX vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Tetratherix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tetratherix FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tetratherix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tetratherix's FCF Margin % falls into.


ASX:TTX
15GF Score
Tetratherix Ltd ASX:TTX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tetratherix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tetratherix's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-3.266/0
= %

Tetratherix's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-6.588/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Tetratherix (ASX:TTX) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tetratherix and its competitors. According to the industry distribution chart, Tetratherix ranks #999999 out of 959 companies in the Biotechnology industry.
Is Tetratherix's FCF Margin % too high?
Tetratherix's current FCF Margin % is 0.00%. Based on the distribution chart, Tetratherix ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tetratherix has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tetratherix ranks #999999 out of 959 companies for FCF Margin %. This places Tetratherix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tetratherix and its competitors. Tetratherix's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Tetratherix's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tetratherix Business Description

Address 34-36 Ralph Street, Unit 29, Alexandria, Sydney, NSW, AUS, 2015
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
15GF Score

Get the complete analysis for ASX:TTX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.12
Price